Shanghai C&D INNOSTIC Medical Technology Group Co., Ltd. (SHE:301584)
China · Delayed Price · Currency is CNY 23.07
-0.26 (-1.11%)
At close: Jun 2, 2026
SHE:301584 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Net Income | 299.65 | 228.31 | 196.3 | 174.28 | 166.94 | 159.67 |
Depreciation & Amortization | 82.7 | 82.7 | 57.7 | 38.99 | 29.05 | 4.78 |
Other Amortization | 21.86 | 21.86 | 12.81 | 5.96 | 4.32 | 4.58 |
Loss (Gain) From Sale of Assets | -0.49 | -0.49 | -0.23 | -0.33 | 0.03 | -1.79 |
Asset Writedown & Restructuring Costs | 0 | 0 | 0.28 | - | 18.25 | 19.68 |
Loss (Gain) From Sale of Investments | - | - | - | -0.73 | - | -0.42 |
Provision & Write-off of Bad Debts | 14.45 | 14.45 | 9.36 | 31.06 | 13.95 | 27.79 |
Other Operating Activities | 1,309 | 237.45 | 199.13 | 116.27 | 47.44 | 11.02 |
Change in Accounts Receivable | -752.03 | -752.03 | -744.35 | -351.09 | 275.23 | -1,125 |
Change in Inventory | -1,000 | -1,000 | -719.35 | -631.22 | -756.46 | -121.08 |
Change in Accounts Payable | 1,340 | 1,340 | 612.83 | 6.73 | -515.74 | 1,025 |
Change in Other Net Operating Assets | 1.39 | 1.39 | 3.48 | 3.81 | - | 8.97 |
Operating Cash Flow | 1,308 | 164.48 | -374.57 | -627.89 | -732.97 | -1.2 |
Capital Expenditures | -120.56 | -121.05 | -82.39 | -33.5 | -10.18 | -6.95 |
Sale of Property, Plant & Equipment | 0.66 | 0.74 | 0.05 | 0.03 | 0.06 | 10.78 |
Cash Acquisitions | - | - | -11.94 | - | - | -3.05 |
Other Investing Activities | -2.39 | - | - | -8.11 | - | - |
Investing Cash Flow | -122.29 | -120.31 | -94.28 | -41.58 | -10.12 | 0.78 |
Long-Term Debt Issued | - | 4,457 | 4,274 | 2,873 | 1,807 | 145.35 |
Long-Term Debt Repaid | - | -4,178 | -3,181 | -1,592 | -688 | -0.03 |
Net Debt Issued (Repaid) | -468.17 | 278.85 | 1,093 | 1,280 | 1,119 | 145.33 |
Common Dividends Paid | -127.02 | -151.89 | -133.61 | -142.35 | -149.11 | -99.2 |
Other Financing Activities | 42.19 | -3.17 | -47 | -24.88 | -364.85 | -5.15 |
Financing Cash Flow | -244.3 | 123.8 | 912.43 | 1,113 | 604.97 | 40.98 |
Foreign Exchange Rate Adjustments | -0.68 | 0 | -0 | -0.01 | 0.01 | -0 |
Miscellaneous Cash Flow Adjustments | 0 | 0 | -0 | -0 | - | - |
Net Cash Flow | 940.37 | 167.96 | 443.58 | 443.65 | -138.12 | 40.56 |
Free Cash Flow | 1,187 | 43.42 | -456.96 | -661.39 | -743.15 | -8.15 |
Free Cash Flow Margin | 6.15% | 0.24% | -2.96% | -5.57% | -7.41% | -0.10% |
Free Cash Flow Per Share | 3.33 | 0.12 | -1.28 | -1.86 | -2.09 | -0.02 |
Cash Income Tax Paid | 287.79 | 266.04 | 234.46 | 162.48 | 158.27 | 131.95 |
Levered Free Cash Flow | - | -14.76 | -627.38 | -671.36 | -806.67 | 30.77 |
Unlevered Free Cash Flow | - | 86.49 | -544.33 | -622.62 | -782.7 | 32.59 |
Change in Working Capital | -419.81 | -419.81 | -849.92 | -993.4 | -1,013 | -226.52 |